Opendata, web and dolomites

LASER OPTIMAL SIGNED

Laser Ablation: SElectivity and monitoRing for OPTImal tuMor removAL

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LASER OPTIMAL project word cloud

Explore the words cloud of the LASER OPTIMAL project. It provides you a very rough idea of what is the project "LASER OPTIMAL" about.

tools    embeddable    unpredictable    alternative    injected    practical    restrained    drive    resection    events    lack    envisaged    monitor    removal    cancer    tissue    assessing    predict    offers    images    optics    develops    extensively    optimal    mass    fiber    prove    clinicians    pros    ablation    driving    invasive    selective    spearing    endoscope    patient    market    retrieve    bnps    light    merge    model    visualize    breaking    surgical    workflow    closed    ambition    biocompatible    artifact    tests    echo    extracted    excellent    tumors    renaissance    surrounding    temperature    routine    loop    laser    fast    industrial    la    healthcare    minimally    ground    guidance    time    despite    innovative    normal    paradigm    investigates    encourage    pancreatic    safe    thermally    treatment    nanoparticles    engineers    solutions    ex    tune    transfer    absorption    performances    destroys    physiological    society    strategy    therapy    anatomy    accurate    human    animal    extendable    interaction    tumor    heat    clinical    benefits    simulate    mini    vivo    insights    dynamics    small    image    re    settings    thermal    trials   

Project "LASER OPTIMAL" data sheet

The following table provides information about the project.

Coordinator
POLITECNICO DI MILANO 

Organization address
address: PIAZZA LEONARDO DA VINCI 32
city: MILANO
postcode: 20133
website: www.polimi.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 1˙499˙575 €
 EC max contribution 1˙499˙575 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2023-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    POLITECNICO DI MILANO IT (MILANO) coordinator 1˙154˙660.00
2    FONDATION DE COOPERATION SCIENTIFIQUE FR (STRASBOURG) participant 184˙290.00
3    BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE US (DUARTE CA) participant 160˙625.00

Map

 Project objective

Laser Ablation (LA) was extensively investigated for its benefits as minimally invasive thermal therapy for tumor. Despite the LA pros as potential alternative to surgical resection (e.g., use of small fiber optics, echo-endoscope procedures and image-guidance without artifact), the lack of tools for safe and patient-specific treatment restrained its clinical use. LASER OPTIMAL offers a renaissance to LA for the practical management of challenging tumors (e.g., pancreatic cancer): it investigates and develops integrated solutions to achieve an effective and selective LA, that thermally destroys the whole tumor mass, while spearing the normal tissue around. The excellent ambition of LASER OPTIMAL is to achieve and merge: a) biocompatible nanoparticles (BNPs) injected in the tumor, to enhance the selective absorption of laser light; b) patient-specific anatomy of tumor and its surrounding, extracted from clinical images, to retrieve the optimal laser settings; c) accurate, fast and real-time heat-transfer model to simulate laser-tissue-BNPs interaction, predict and visualize the treatment dynamics; d) real-time temperature measurement system to monitor LA effects, account for unpredictable physiological events and tune the settings (closed-loop). The design of ex vivo and in vivo animal tests allows assessing the system performances and driving the possible workflow re-design. Finally, human trials are envisaged to prove the significant impact of the LASER OPTIMAL paradigm. The collaboration of researchers, engineers and clinicians will drive the use of this innovative strategy in clinical routine. The research on the patient-specific system for the mini-invasive tumors removal, and the ground-breaking insights on clinical use of BNPs will strongly impact on EU healthcare system and society, by creating a novel product. This paradigm is also embeddable in existing system of industrial partner, extendable to other procedures, thus able to encourage a dedicated market.

 Publications

year authors and title journal last update
List of publications.
2018 Paola Saccomandi, Alfonso Lapergola, Fabio Longo, Emiliano Schena, Giuseppe Quero
Thermal ablation of pancreatic cancer: A systematic literature review of clinical practice and pre-clinical studies
published pages: 398-418, ISSN: 0265-6736, DOI: 10.1080/02656736.2018.1506165
International Journal of Hyperthermia 35/1 2020-04-24

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LASER OPTIMAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LASER OPTIMAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

FuncMAB (2019)

High-throughput single-cell phenotypic analysis of functional antibody repertoires

Read More  

BABE (2018)

Why is the world green: testing top-down control of plant-herbivore food webs by experiments with birds, bats and ants

Read More  

UncertainENV (2019)

The Power of Randomization in Uncertain Environments

Read More